Pioneer of Lavender Fertilized ACL Technique Available for Interviews

FOR IMMEDIATE RELEASE

Contact: Mitch Vingle
304.905.6005

mitch@wheelhousecreativellc.com

Dr. Chad Lavender of Marshall Orthopaedics in Teays Valley, West Virginia, is open to interview requests regarding a significant medical breakthrough, outlined in a new textbook called “Biologic and Nanoarthroscopic Approaches in Sports Medicine,” available through Amazon.

The breakthrough has given patients facing anterior cruciate ligament (ACL) reconstruction hope of much earlier recovery time.

Lavender, a board-certified orthopedic surgeon and assistant professor at Marshall University Joan C. Edwards School of Medicine, has developed and tested the Lavender Fertilized ACL technique that’s given patients startling functional knee improvement at 12 weeks over that of a standard ACL reconstruction.

“In our clinical trial, the fertilized patients at 12 weeks test at 80 percent of their opposite knee – which is over twice the average for the control group,” Lavender said. “This is a faster return to limb symmetry than a standard ACL reconstruction, which is six to nine months.

“No one has ever tested patients at 12 weeks before.”

The Lavender Fertilized ACL procedure is a minimally invasive technique that uses a mixture of bone marrow concentrate, autograft bone and demineralized bone matrix to fill the tunnels within the knee joint during ACL reconstruction. The technique utilizes an innovative concept of internal brace reinforcement to improve stability of the healing ACL.

The results of the clinical trial – the study group’s 80 percent return to normal function in 12 weeks — dwarfs the usual 35 percent of a standard ACL reconstruction in the same time frame. The normal ACL recovery of six to nine months can sometimes extend out to a year.

The important Marshall Orthopaedics study is a prospective, randomized clinical trial that provides the highest level of evidence possible. Dr. Lavender and Marshall Orthopaedics have over 40 patients enrolled in the study from 14 to 40 years old.

“Our P Value for the trial is .0001,” Dr. Lavender said. “It only has to be .05 to be considered statistically significant.”

P Value is used in hypothesis testing to help support or reject the null hypothesis. The smaller the P Value, the greater the statistical significance of the observed difference.

“At 80 percent at 12 weeks, patients are ready to functionally begin the process to return to their sport, if that’s the goal,” Dr. Lavender said. “With traditional ACL surgery, we would not even test patients until the six-month time point.”

The clinical trial is continuing and plans for multi-site testing are underway.

Dr. Lavender has published nearly a dozen articles in the last two years and has released a surgical textbook this spring called “Biologic and Nanoarthroscopic Techniques in Sports Medicine,” which provides the most up-to-date techniques for surgeons to use worldwide. Dr. Lavender has consulted and given lectures worldwide on the procedure.

To schedule an interview with Dr. Lavender, please contact Mitch Vingle of Wheelhouse Creative LLC at 304-395-1145.

Patient testimonials, a bio of Dr. Lavender and a feature on Dr. Lavender and the technique are available online at LavenderACL.com.

–end–